In 2024, the aesthetic services market reached $19.7B, with non-surgical procedures dominating patient preferences. The market is projected to grow to $28.39B by 2029, driven by demand for combination treatments and minimally invasive procedures. 

InMode helps you meet this growing demand by providing a variety of non-invasive treatments such as Morpheus8, that address the needs of your patients safely and with minimal downtime.

As non-surgical treatments continue to drive market growth toward $21.16 billion in 2025, clinic owners face critical challenges:

• Keeping pace with changing patient preferences
• Maintaining competitive advantages
• Protecting technology investments
• Scaling treatment capabilities efficiently

• Multi-modality approach for comprehensive treatment offerings
• Customizable solutions for diverse patient needs
• Recurring revenue through repeatable procedures
• User-friendly design with intelligent controls
• Enhanced power and faster outcomes

• Adaptable platform that grows with
  your practice
• Comprehensive solution for today's most in-demand treatments
• Multiple revenue streams from one system
• Cutting-edge technology backed by clinical validation

Morpheus8 is the first and only FDA cleared fractional radiofrequency device for soft tissue contraction. It is a versatile tool that safely and efficaciously meets patient demand for dermal contraction and subdermal adipose treatments.

Equipped with SCALE functionalities, Morpheus8 automatically deploys bipolar RF to multi-level treatment depths and programmable energy levels with a single pulse.

Morpheus8 features four interchangeable fractional tips with different microneedling configurations:

• 12 pin Morpheus8 Prime
• 24 pin Morpheus8
• 24 pin Morpheus8 Resurfacing
• 40 pin Morpheus8 Deep

With premium per-session pricing and low overhead, Morpheus8 delivers consistent profitability for aesthetic practices looking to scale.

Whether treating face or body, Morpheus8 combines high patient demand with strong margins.

Just 25 treatments per month (e.g., 20 face + 5 body) can result in dependable six-figure income.

Boost patient retention and maximize lifetime value per client by offering combination treatments and multi-session packages.

Disclaimer: Revenue figures are estimates based on average treatment pricing and patient volume. Actual results may vary by clinic.

InMode technologies deliver multiple non-invasive and hands-free procedures so you can address the growing patient demand while reducing patient-physician face-to-face contact during procedures. Our goal is to help you increase productivity, revenue, and patient satisfaction.

OptimasMAX is a multi-functional platform that gives you the ability to provide the most in-demand consumer procedures, including fractional radiofrequency (FRF), intense pulsed light (IPL), hair removal, and vascular treatments. The system integrates advanced Morpheus8 technology, enhanced Lumecca Peak IPL, and intelligent thermal monitoring for consistent, optimal results.

Morpheus8 is a minimally invasive RF fractional skin treatment. It delivers the deepest fractional treatments available, heating subdermal tissue up to 8mm (7mm + 1mm thermal profile).

EvolveX is the ultimate hands-free platform for a body transformation. Patients continue to seek non-invasive treatments at unprecedented levels, pursuing non-invasive alternatives for body treatments. This all-in-one platform delivers multiple technologies on one system.

Define’s hybrid approach — combining hands-free and technician-operated  technologies like Morpheus8 and Forma—effectively addresses the complex topography of the face, enabling customized combination procedures across all facial regions.

The world’s first patented multi-wavelength workstation, Triton is the only hair removal option that combines the three most popular wavelengths in one platform, using Fusion Technology, for permanent results on skin types up to VI.

Get a call from our dedicated concierge team to learn more about how InMode's workstations can benefit your practice and help you meet the growing demand for non-invasive cosmetic treatments.

Not all products are approved in all countries. Check availability and approved intended use with our local representative.

Clinical and peer-reviewed publications are published by a third party and based on physician experiences and study results. InMode does not take responsibility for or endorse the content provided by the independent practitioners as the language may differ than InMode manufacturer clearances.

17 Hughes

Irvine CA 92618